{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:32:29Z","timestamp":1793140349067,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.eclinm.2026.104139","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T15:08:55Z","timestamp":1786806535000},"page":"104139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bone marrow failure syndromes across the age spectrum: diagnostic and therapeutic principles"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9172-4706","authenticated-orcid":false,"given":"Jibran","family":"Durrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma M.","family":"Groarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkael A.","family":"Sekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.104139_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41431-025-01952-4","article-title":"Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers","author":"Villy","year":"2025","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104139_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00277-018-3486-3","article-title":"Incidence and treatment outcome of aplastic anemia in Taiwan-real-world data from single-institute experience and a nationwide population-based database","volume":"98","author":"Li","year":"2019","journal-title":"Ann Hematol"},{"issue":"17","key":"10.1016\/j.eclinm.2026.104139_bib3","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2026.104139_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010340.pub2","article-title":"Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria","author":"Mart\u00ed-Carvajal","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104139_bib5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1182\/blood.2020006481","article-title":"Inherited bone marrow failure in the pediatric patient","volume":"140","author":"Dokal","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104139_bib6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.pcl.2013.09.007","article-title":"The inherited bone marrow failure syndromes","volume":"60","author":"Chirnomas","year":"2013","journal-title":"Pediatr Clin North Am"},{"issue":"12","key":"10.1016\/j.eclinm.2026.104139_bib7","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00439-022-02462-9","article-title":"Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair","volume":"141","author":"Peake","year":"2022","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104139_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2010.08212.x","article-title":"Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study","volume":"150","author":"Alter","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104139_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/hematology.2022000394","article-title":"Dyskeratosis congenita and telomere biology disorders","volume":"2022","author":"Savage","year":"2022","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104139_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.seminhematol.2017.04.004","article-title":"Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia","volume":"54","author":"Savage","year":"2017","journal-title":"Semin Hematol"},{"issue":"12","key":"10.1016\/j.eclinm.2026.104139_bib11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","article-title":"An update on the biology and management of dyskeratosis congenita and related telomere biology disorders","volume":"12","author":"Niewisch","year":"2019","journal-title":"Expert Rev Hematol"},{"issue":"13","key":"10.1016\/j.eclinm.2026.104139_bib12","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood.2022017739","article-title":"Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: biological insights and clinical advances","volume":"141","author":"Reilly","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104139_bib13","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2352-3026(19)30206-6","article-title":"Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study","volume":"7","author":"Myers","year":"2020","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104139_bib14","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S2352-3026(24)00063-2","article-title":"Diagnosis, treatment, and surveillance of diamond-blackfan anaemia syndrome: international consensus statement","volume":"11","author":"Wlodarski","year":"2024","journal-title":"Lancet Haematol"},{"issue":"13","key":"10.1016\/j.eclinm.2026.104139_bib15","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood.2022017764","article-title":"The spectrum of GATA2 deficiency syndrome","volume":"141","author":"Calvo","year":"2023","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104139_bib16","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/humu.24271","article-title":"GATA2 deficiency syndrome: a decade of discovery","volume":"42","author":"Homan","year":"2021","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104139_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1182\/blood.2022017717","article-title":"Genetic and clinical spectrum of SAMD9 and SAMD9L syndromes: from variant interpretation to patient management","volume":"145","author":"Sahoo","year":"2025","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104139_bib18","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","article-title":"Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes","volume":"27","author":"Sahoo","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104139_bib19","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41375-018-0074-4","article-title":"SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies","volume":"32","author":"Davidsson","year":"2018","journal-title":"Leukemia"},{"issue":"14","key":"10.1016\/j.eclinm.2026.104139_bib20","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJMra1904794","article-title":"Myelodysplastic syndromes","volume":"383","author":"Cazzola","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104139_bib21","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2022.14578","article-title":"Diagnosis and treatment of myelodysplastic syndromes: a review","volume":"328","author":"Sekeres","year":"2022","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104139_bib22","first-page":"1974","article-title":"Germline and somatic genetic landscape of pediatric myelodysplastic syndromes","volume":"110","author":"Kotmayer","year":"2025","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.eclinm.2026.104139_bib23","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/s41375-022-01729-4","article-title":"Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia","volume":"36","author":"Kubota","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104139_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/hematology.2021000245","article-title":"When does a PNH clone have clinical significance?","volume":"2021","author":"Babushok","year":"2021","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104139_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.seminhematol.2022.08.001","article-title":"Clonality in immune aplastic anemia: mechanisms of immune escape or malignant transformation","volume":"59","author":"Durrani","year":"2022","journal-title":"Semin Hematol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104139_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104139_bib27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1182\/hematology.2023000488","article-title":"When to consider inherited marrow failure syndromes in adults","volume":"2023","author":"Gutierrez-Rodrigues","year":"2023","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104139_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.6004\/jnccn.2025.0013","article-title":"NCCN guidelines\u00ae insights: myelodysplastic syndromes, version 2.2025: featured updates to the NCCN guidelines","volume":"23","author":"Greenberg","year":"2025","journal-title":"J Natl Compr Cancer Netw"},{"issue":"12","key":"10.1016\/j.eclinm.2026.104139_bib29","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.1016\/S2352-3026(23)00265-X","article-title":"Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the chronic malignancies working party of the EBMT","volume":"10","author":"Gurnari","year":"2023","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104139_bib30","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/bjh.70387","article-title":"Expanding genetic landscape of inherited bone marrow failure syndromes: insights from the Canadian Inherited Marrow Failure Registry (CIMFR) (2001-2023)","volume":"208","author":"Shim","year":"2026","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104139_bib31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3324\/haematol.13829","article-title":"Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study","volume":"94","author":"Phillip","year":"2009","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104139_bib32","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British society for haematology guideline","volume":"204","author":"Kulasekararaj","year":"2024","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104139_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3324\/haematol.10075","article-title":"Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)","volume":"92","author":"Locasciulli","year":"2007","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.eclinm.2026.104139_bib34","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia","volume":"376","author":"Townsley","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104139_bib35","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1182\/bloodadvances.2024015301","article-title":"Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapy","volume":"9","author":"Durrani","year":"2025","journal-title":"Blood Adv"},{"issue":"18","key":"10.1016\/j.eclinm.2026.104139_bib36","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"124","author":"Brodsky","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104139_bib37","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2500171","article-title":"Clonal selection and evolution after treatment of severe aplastic anemia","volume":"5","author":"Gutierrez-Rodrigues","year":"2026","journal-title":"NEJM Evid"},{"issue":"7","key":"10.1016\/j.eclinm.2026.104139_bib38","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00277-023-05269-4","article-title":"Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry","volume":"102","author":"Dingli","year":"2023","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104139_bib39","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104139_bib40","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1182\/blood-2007-08-019729","article-title":"Telomere maintenance and human bone marrow failure","volume":"111","author":"Calado","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104139_bib41","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jtct.2025.10.021","article-title":"Long-term Follow-Up of the Baltimore experience with hematopoietic cell transplantation for severe aplastic anemia using post-transplantation cyclophosphamide","volume":"32","author":"DeZern","year":"2026","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104139_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.2021012130","article-title":"Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study","volume":"139","author":"Patel","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104139_bib43","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/s41375-022-01636-8","article-title":"Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia","volume":"36","author":"Groarke","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104139_bib44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1200\/JCO.22.00710","article-title":"Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria","volume":"41","author":"Gurnari","year":"2023","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.eclinm.2026.104139_bib45","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1182\/blood-2016-01-583625","article-title":"How I treat MDS and AML in Fanconi anemia","volume":"127","author":"Peffault de Latour","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104139_bib46","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa2029073","article-title":"Pegcetacoplan versus eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"384","author":"Hillmen","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104139_bib47","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa2308695","article-title":"Oral iptacopan monotherapy in paroxysmal nocturnal hemoglobinuria","volume":"390","author":"Peffault de Latour","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104139_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/hematology.2019000019","article-title":"Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome","volume":"2019","author":"Durrani","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104139_bib49","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1038\/s41375-019-0457-1","article-title":"Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome","volume":"33","author":"Bono","year":"2019","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104139_bib50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.hoc.2009.01.015","article-title":"Hypocellular myelodysplasia","volume":"23","author":"Sloand","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"26","key":"10.1016\/j.eclinm.2026.104139_bib51","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.eclinm.2026.104139_bib52","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.eclinm.2026.104139_bib53","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.mayocp.2018.04.002","article-title":"Clinical implications of clonal hematopoiesis","volume":"93","author":"Steensma","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104139_bib54","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2352-3026(23)00340-X","article-title":"Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study","volume":"11","author":"Cargo","year":"2024","journal-title":"Lancet Haematol"},{"issue":"8","key":"10.1016\/j.eclinm.2026.104139_bib55","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1182\/bloodadvances.2025018770","article-title":"A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS natural history study","volume":"10","author":"DeZern","year":"2026","journal-title":"Blood Adv"},{"issue":"19","key":"10.1016\/j.eclinm.2026.104139_bib56","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2024024756","article-title":"Risk prediction for clonal cytopenia: multicenter real-world evidence","volume":"144","author":"Xie","year":"2024","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.eclinm.2026.104139_bib57","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1182\/blood-2015-08-667063","article-title":"MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance","volume":"126","author":"Kwok","year":"2015","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.eclinm.2026.104139_bib58","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2017-01-763425","article-title":"Clinical significance of somatic mutation in unexplained blood cytopenia","volume":"129","author":"Malcovati","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2026.104139_bib59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gde.2020.12.004","article-title":"Insights into clonal hematopoiesis and its relation to cancer risk","volume":"66","author":"Mitchell","year":"2021","journal-title":"Curr Opin Genet Dev"},{"issue":"8","key":"10.1016\/j.eclinm.2026.104139_bib60","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1016\/S2352-3026(25)00137-1","article-title":"Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over time","volume":"12","author":"Kirschner","year":"2025","journal-title":"Lancet Haematol"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104139_bib61","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1093\/annonc\/mdq233","article-title":"Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients","volume":"21","author":"Schroeder","year":"2010","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104139_bib62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.eclinm.2026.104139_bib63","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"issue":"7","key":"10.1016\/j.eclinm.2026.104139_bib64","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104139_bib65","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ajh.27611","article-title":"Elderly patients with aplastic anemia: treatment patterns and outcomes in the real world","volume":"100","author":"Fattizzo","year":"2025","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104139_bib66","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/bjh.19648","article-title":"Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia","volume":"205","author":"Prabahran","year":"2024","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104139_bib67","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1016\/S2352-3026(22)00206-X","article-title":"Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial","volume":"9","author":"DeZern","year":"2022","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104139_bib68","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41 in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.eclinm.2026.104139_bib69","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2015-10-676098","article-title":"Novel germ line DDX41 mutations define families with a lower age of MDS\/AML onset and lymphoid malignancies","volume":"127","author":"Lewinsohn","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104139_bib70","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1182\/blood.2022018221","article-title":"Germ line DDX41 mutations define a unique subtype of myeloid neoplasms","volume":"141","author":"Makishima","year":"2023","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.eclinm.2026.104139_bib71","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.2022017715","article-title":"DDX41-associated susceptibility to myeloid neoplasms","volume":"141","author":"Makishima","year":"2023","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104139_bib72","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/ajh.27070","article-title":"Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants","volume":"98","author":"Bataller","year":"2023","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104139_bib73","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1007\/s00277-025-06278-1","article-title":"Clinicopathological and prognostic significance of DDX41 mutation in myeloid neoplasms: a systematic review and meta-analysis","volume":"104","author":"Miao","year":"2025","journal-title":"Ann Hematol"},{"issue":"10399","key":"10.1016\/j.eclinm.2026.104139_bib74","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(23)00874-7","article-title":"Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial","volume":"402","author":"Platzbecker","year":"2023","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.eclinm.2026.104139_bib75","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/bloodadvances.2018019414","article-title":"The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort","volume":"2","author":"Stahl","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104139_bib76","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bjh.70404","volume":"208","author":"Speight","year":"2026","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.eclinm.2026.104139_bib77","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood.2022015790","article-title":"Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages","volume":"140","author":"Feurstein","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104139_bib78","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bjh.70284","article-title":"Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis","volume":"208","author":"Jin","year":"2026","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104139_bib79","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/07853890.2015.1009156","article-title":"Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapy","volume":"47","author":"Dan","year":"2015","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104139_bib80","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41591-018-0267-4","article-title":"Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level","volume":"25","author":"Chen","year":"2019","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104139_bib81","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/bloodadvances.2025017934","article-title":"American society of hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults","volume":"10","author":"Sekeres","year":"2026","journal-title":"Blood Adv"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:34:18Z","timestamp":1793136858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026003925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":81,"alternative-id":["S2589537026003925"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104139","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow failure syndromes across the age spectrum: diagnostic and therapeutic principles","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104139"}}